Publications

Chapters, Manuals & Briefs

• Pink Book’s Chapter on Tetanus
  Epidemiology & Prevention of Vaccine-Preventable Diseases
• Travelers Health: Yellow Book — Chapter on Tetanus
• Surveillance Manual’s Chapter on Tetanus
  Manual for the Surveillance of Vaccine-Preventable Diseases

Articles

Vaccine Recommendations and Licensures

• Liang JL, Tiwari T, Moro P, et al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2018;67(2):1–44.
• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women — Advisory Committee on Immunization Practices (ACIP), 2012
  MMWR. 2013;62(07):131-5.
• Updated Recommendation for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Adults 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
  MMWR. 2012;61(25):468–70.
• Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  MMWR. 2011;60(RR07):1–45.
• Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged Less than 12 Months — Advisory Committee on Immunization Practices (ACIP), 2011
  MMWR. 2011;60(41):1424–6.
• FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
  MMWR. 2011;60(37):1279–80.
• Updated Recommendations for the Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
  MMWR 2011;60(01):13–15.
• Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  MMWR 2008;57(04):1–47, 51.
• Recommendations for Postexposure Interventions to Prevent Infection with Hepatitis B Virus, Hepatitis C Virus, or Human Immunodeficiency Virus, and Tetanus in Persons Wounded During Bombings and Other Mass-Casualty Events — United States, 2008
  MMWR 2008;57(RR06):1–19.
• Preventing Tetanus, Diphtheria, and Pertussis Among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
  MMWR 2006;55(RR17):1–33.
• Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines
  MMWR 2006;55(RR03):1–34.
• Notice to Readers: FDA Approval of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed, (INFANRIX^®) for Fifth Consecutive DTaP Vaccine Dose
  MMWR 2003;52(38):921.
• Notice to Readers: FDA Licensure of Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant), and Poliovirus Vaccine Combined, PEDIARIX™) for Use in Infants
  MMWR 2003;52(10):203–204.
• Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
  MMWR 2000; 49(RR13):1–8.
• Combination Vaccines for Childhood Immunization
  MMWR 1999;48(RR05):1–15.
• Diphtheria, Tetanus, and Pertussis: Recommendations for Vaccine Use and Other Preventive Measures Recommendations of the Immunization Practices Advisory Committee (ACIP)
  MMWR 1991; 40(RR10):1–28.

Surveillance

• Tetanus Surveillance — United States, 2001–2008
  MMWR. 2011;60(12):365–9.
• Tetanus Surveillance — United States, 1998–2000
  MMWR. 2003;52(S S03):1–8.
• Tetanus Surveillance — United States, 1995–1997
  MMWR. 1998;47(SS–2):1–13.
• Tetanus Surveillance — United States, 1991–1994
  MMWR. 1997;46(SS–2):15–25.

 Top of Page